Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

4.2%

6 terminated/withdrawn out of 143 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

10%

15 trials in Phase 3/4

Results Transparency

3%

1 of 30 completed trials have results

Key Signals

21 recruiting1 with results4 withdrawn

Enrollment Performance

Analytics

Phase 1
31(29.8%)
N/A
30(28.8%)
Phase 2
25(24.0%)
Phase 4
12(11.5%)
Phase 3
3(2.9%)
Early Phase 1
3(2.9%)
104Total
Phase 1(31)
N/A(30)
Phase 2(25)
Phase 4(12)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (143)

Showing 20 of 143 trials
NCT07534371Active Not Recruiting

Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study

Role: collaborator

NCT07106658Not ApplicableCompleted

TEAS for Variceal Bleeding Endoscopy in Cirrhosis

Role: lead

NCT07440342Not ApplicableRecruiting

TEAS for Sedation During ERCP: A Multicenter Trial

Role: lead

NCT07481032Not ApplicableNot Yet Recruiting

Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study

Role: collaborator

NCT06357806Not ApplicableActive Not Recruiting

The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients

Role: lead

NCT07299123Phase 1Enrolling By Invitation

Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA

Role: collaborator

NCT07367542Not ApplicableNot Yet Recruiting

Effect of Esketamine on Perioperative Negative Emotions in Patients Undergoing Breast Cancer Surgery

Role: collaborator

NCT07297173Phase 1Recruiting

Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia

Role: lead

NCT07238686Phase 2Recruiting

Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS

Role: lead

NCT03736707Not ApplicableRecruiting

High-Frequency Oscillation Ventilation Versus Conventional Mechanical Ventilation in Very Preterm Infants With Perinatal Acute Respiratory Distress Syndrome: Multicenters Randomized Controlled, Superiority Trial

Role: collaborator

NCT07186621Phase 3Recruiting

Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC

Role: collaborator

NCT04138719Phase 2Recruiting

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer

Role: collaborator

NCT04159142Phase 2Recruiting

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer

Role: collaborator

NCT06556862Phase 2Not Yet Recruiting

Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor

Role: lead

NCT05939167Phase 1Recruiting

Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage

Role: collaborator

NCT07078591Phase 2Recruiting

Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML

Role: lead

NCT03591796Not ApplicableCompleted

Invasive Ventilation for Neonates With Acute Respiratory Distress Syndrome(ARDS)

Role: collaborator

NCT06926647Not Yet Recruiting

A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B

Role: lead

NCT02583685Phase 2Completed

Switching Regimen in Treating Cirrhotic HCV GT1b Subjects

Role: collaborator

NCT03188146Completed

Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic Acid

Role: collaborator